http://www.zymeworks.com
Zymeworks Inc. Company Intro
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
Industry
Healthcare
Zymeworks Inc. Headquaters
1385 West 8th Avenue
Vancouver,V6H 3V9
Canada
Zymeworks Inc. Share price
17 May 2023 14:09 GMT
$9.05
0.02 (0.22 %)
Zymeworks Inc. Market cap
$573.05 M
WMC RANKING
2023
Zymeworks Inc. # 120
BiotechnologyLatest Zymeworks Inc. News
02 Oct 2023
Investment Firm Shows Confidence in Zymeworks Inc. with ...
Zymeworks Inc., a biotechnology company specializing in the development of multifunctional protein therapeutics, has recently garnered attention from various...
02 Oct 2023
Investment Firm Shows Confidence in Zymeworks Inc. with ...
Zymeworks Inc., a biotechnology company specializing in the development of multifunctional protein therapeutics, has recently garnered attention from various...
30 Sep 2023
Burlington Stores Sees Unusually High Options Trading Activity
Burlington Stores, Inc. (NYSE: BURL) experienced a surge in options trading on Friday, with traders purchasing 8,145 put options on the stock.
WMC Market Score
WMC Market to Revenue Score
Zymeworks Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Zymeworks Inc. | USD | $31,326 | $227,849 | $-194,006 | $5,731M | 120 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Zymeworks Inc. Social Followers vs Top 4 Industry Competitors
Zymeworks Inc. Post vs Top 4 Industry Competitors
Zymeworks Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Zymeworks Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Zymeworks Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Zymeworks Inc. | 0.34 | 0.57 | 0.03 | 0 | 0 | 0 | 0.26 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
